Skip to main content
main-content
Top

13-05-2020 | COVID-19 | Podcast | Article

A closer look at the ACR guidance on COVID-19 and rheumatology care

Speaker: Ted Mikuls

In April 2020, the American College of Rheumatology issued guidance for the management of people with rheumatic diseases during the COVID-19 pandemic.

We spoke to lead author Ted Mikuls, from the University of Nebraska Medical Center in the USA, to find out more about what rheumatologists should do to best care for their patients in light of COVID-19, and what some of the unanswered questions are.

13 May 2020: The coronavirus pandemic is affecting all healthcare professionals across the globe. Medicine Matters’ focus, in this difficult time, is the dissemination of the latest data to support you in your research and clinical practice, based on the scientific literature. We will update the information we provide on the site, as the data are published. However, please refer to your own professional and governmental guidelines for the latest guidance in your own country.

Listen below or subscribe to this Podcast on:

Google PodcastsApple Podcasts | SpotifyStitcher | TuneIn

Related topics

Repurposing rheumatology drugs for COVID-19

Experts discuss the rationale, data on different agents, and the potential impact on rheumatology practice.

  • » Featuring insights from the COVID-19 Global Rheumatology Alliance, EULAR, and the Lupus Foundation of America
Image Credits